In this study, using both BCR-ABL induced B-ALL mouse model and human B-ALL cells, we found that the activation of JNK could not be inhibited by BCR-ABL TKI in B-ALL cells. Here, ABL1 is linked to precursor B-cell acute lymphoblastic leukemia.